Oncologix Tech, Inc. Announces Earnings Results for the Second Quarter and Revenue Results for the Six Months Ended February 28, 2015; Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2015
For the six months, the company announced revenues of $2,389,751 up 74% from $1,708,391 for the comparable periods in fiscal 2014.
The company provided earnings guidance for the third quarter and full year of fiscal 2015. For the quarter, the company expects to report revenues of $1,289,271, gross profit of $366,888, depreciation and amortization of $4,688, loss before interest and taxes of $102,224.
The company announced that it is confident in its ability to move forward with the acquisition and also execute upon its continued acquisition and growth strategy to grow its annualized revenues to $25 million by year-end 2015 with positive EBITDA exceeding $2.6 million.